BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9

• Press Releases

  Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026

  March 3, 2026

   · 

  4 min read
• Press Releases

  AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression

  March 3, 2026

   · 

  7 min read
• Press Releases

  Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma

  March 3, 2026

   · 

  6 min read
• Press Releases

  Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

  March 3, 2026

   · 

  4 min read
• Press Releases

  SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results

  March 3, 2026

   · 

  1 min read
• Press Releases

  Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference

  March 3, 2026

   · 

  1 min read
• Press Releases

  Aclaris Therapeutics to Participate in the Leerink Partners 2026 Global Healthcare Conference

  March 3, 2026

   · 

  1 min read
• Press Releases

  Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication

  March 3, 2026

   · 

  7 min read
• Press Releases

  Priovant Announces FDA Acceptance and Priority Review of New Drug Application for Brepocitinib in Dermatomyositis

  March 3, 2026

   · 

  7 min read
• Press Releases

  ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026

  March 3, 2026

   · 

  4 min read